Matinas BioPharma Inc.

AMEX: MTNB · Real-Time Price · USD
0.94
0.01 (0.92%)
At close: Jun 17, 2025, 12:38 PM

Matinas BioPharma Revenue

Matinas BioPharma reported an annual revenue of $0, reflecting a -100% growth. For the quarter ending March 31, 2025, Matinas BioPharma generated $0 in revenue.
Revenue (ttm)
$0
Revenue Growth
-100%
Price / Sales Ratio
0
Revenue / Employee
$0
Employees
3
Market Cap
4.77M

Revenue Chart

Revenue History

Fiscal Year End Revenue % Change
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.